(Q44750674)

5 December 2017

title

Clinical features of psychotic disorders and polymorphisms in HT2A, DRD2, DRD4, SLC6A3 (DAT1), and BDNF: a family based association study (English)

1 reference

5 December 2017

1 reference

4

1 reference

5 December 2017

7

K S Kendler

1 reference

5 December 2017

2

M C Neale

1 reference

5 December 2017

Ayman H Fanous

1

1 reference

5 December 2017

R E Straub

series ordinal

3

1 reference

5 December 2017

A F O'Neill

series ordinal

5

1 reference

5 December 2017

D Walsh

series ordinal

6

1 reference

5 December 2017

publication date

1 February 2004

1 reference

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics

5 December 2017

published in

1 reference

5 December 2017

volume

125B

1 reference

5 December 2017

issue

1

1 reference

5 December 2017

page(s)

69-78

1 reference

Negative symptoms in schizophrenia. Definition and reliability

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20103

Negative v positive schizophrenia. Definition and validation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20103

Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20103

Symptomatic and neuropsychological components of defect states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20103

Serotonin and the neurobiology of depression. Effects of tryptophan depletion in drug-free depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20103

Functional and anatomical aspects of prefrontal pathology in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20103

Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20103

The genetics of schizophrenia: a current, genetic-epidemiologic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20103

Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20103

Classical Subtypes for Schizophrenia: Literature Review for DSM-IV

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20103

Implications of normal brain development for the pathogenesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20103

Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.20103

21 January 2018

Identifiers

DOI

10.1002/AJMG.B.20103

1 reference

5 December 2017

1 reference